Applied DNA Sciences Inc Warrant
APDNW
APDNW was delisted on the 18th of November, 2019.
5 hedge funds and large institutions have $396K invested in Applied DNA Sciences Inc Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
54% less capital invested
Capital invested by funds: $870K → $396K (-$474K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$120K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2K |
APDNW Hedge Fund Activity: Q4 2017 in Review
5 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Applied DNA Sciences Inc Warrant (APDNW) for Q4 2017, worth a combined $396K — down 54% from $870K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of APDNW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, cutting an estimated $120K.
- 5 institutional investors held Applied DNA Sciences Inc Warrant (APDNW) as of Q4 2017, down from 6 in Q3 2017.
- Funds reported $396K of Applied DNA Sciences Inc Warrant stock for Q4 2017, down 54% quarter-over-quarter.
- 0 funds opened new Applied DNA Sciences Inc Warrant positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest Applied DNA Sciences Inc Warrant seller in Q4 2017 was Sabby Management, an estimated $120K sold.
Based on aggregated 13F filings for Q4 2017.